Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Accured Expenses (2016 - 2025)

Fortress Biotech has reported Change in Accured Expenses over the past 13 years, most recently at -$169000.0 for Q4 2025.

  • Quarterly results put Change in Accured Expenses at -$169000.0 for Q4 2025, down 123.21% from a year ago — trailing twelve months through Dec 2025 was -$1.7 million (up 73.74% YoY), and the annual figure for FY2025 was -$1.7 million, up 73.74%.
  • Change in Accured Expenses for Q4 2025 was -$169000.0 at Fortress Biotech, down from $6.3 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for FBIO hit a ceiling of $16.2 million in Q4 2023 and a floor of -$16.9 million in Q3 2023.
  • Median Change in Accured Expenses over the past 5 years was -$46500.0 (2021), compared with a mean of -$21050.0.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 18554.35% in 2022 and later plummeted 35908.51% in 2023.
  • Fortress Biotech's Change in Accured Expenses stood at -$46000.0 in 2021, then skyrocketed by 18554.35% to $8.5 million in 2022, then soared by 91.21% to $16.2 million in 2023, then plummeted by 95.52% to $728000.0 in 2024, then plummeted by 123.21% to -$169000.0 in 2025.
  • The last three reported values for Change in Accured Expenses were -$169000.0 (Q4 2025), $6.3 million (Q3 2025), and -$8.4 million (Q2 2025) per Business Quant data.